Series C - ByHeart

Series C - ByHeart

Investment Firm

Overview

ByHeart is a baby nutrition company with FDA-registered infant formula.

Announced Date

May 13, 2024

Funding Type

Series C

Highlights

Location

New York, New York, United States, North America

Social

Investor Lead

N/A

Participant Investors

6

Investor Name
Participant InvestorBellco Capital
Participant InvestorAF Ventures
Participant InvestorRed Sea Ventures
Participant InvestorGaingels
Participant InvestorPolaris Partners

Round Details and Background

ByHeart raised $95000000 on 2024-05-13 in Series C

ByHeart is a baby nutrition company with FDA-registered infant formula.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 26, 2021
Series B - ByHeart
9-90.0M
Jun 25, 2019
Debt Financing - ByHeart
-22.0M
Mar 01, 2023
Debt Financing - ByHeart
1-undefined
May 13, 2024
Series C - ByHeart
8-95.0M

Recent Activity

There is no recent news or activity for this profile.